Health ❯Healthcare ❯Pharmaceuticals ❯Drug Approval

FDA

Patient Care Pharmaceuticals Public Health Medical Treatments Clinical Trials Pain Management Drug Approval Regulatory Affairs Drug Development Drug Development

3 ARTICLES

last mo.

Sotatercept cuts risk of death and hospitalization by 76% in advanced pulmonary arterial hypertension

Published in The New England Journal of Medicine on May 28, the Zenith trial marks the first demonstration of a survival benefit for sotatercept in late-stage pulmonary arterial hypertension

16 ARTICLES

2mo ago

FDA Approves First Blood Test for Alzheimer’s Diagnosis

37 ARTICLES

5mo ago

FDA Approves Journavx, First Non-Opioid Painkiller in Over 20 Years